HEADER OXIDOREDUCTASE 26-OCT-07 3B5P TITLE CRYSTAL STRUCTURE OF A CADD-LIKE PROTEIN OF UNKNOWN FUNCTION TITLE 2 (NPUN_F6505) FROM NOSTOC PUNCTIFORME PCC 73102 AT 2.00 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CADD-LIKE PROTEIN OF UNKNOWN FUNCTION; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC PUNCTIFORME; SOURCE 3 ORGANISM_TAXID: 63737; SOURCE 4 STRAIN: PCC 73102; SOURCE 5 GENE: ZP_00108531.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 24-JUL-19 3B5P 1 REMARK LINK REVDAT 5 25-OCT-17 3B5P 1 REMARK REVDAT 4 13-JUL-11 3B5P 1 VERSN REVDAT 3 23-MAR-11 3B5P 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3B5P 1 VERSN REVDAT 1 13-NOV-07 3B5P 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF CADD-LIKE PROTEIN OF UNKNOWN FUNCTION JRNL TITL 2 (ZP_00108531.1) FROM NOSTOC PUNCTIFORME PCC 73102 AT 2.00 A JRNL TITL 3 RESOLUTION (MONOCLINIC FORM) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 16827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 851 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1076 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.43 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 27.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.58000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : 1.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.95000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.171 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.163 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.118 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.380 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1901 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1241 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2584 ; 1.434 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3043 ; 1.031 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 244 ; 6.143 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 85 ;37.608 ;25.059 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 317 ;14.666 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;14.276 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 291 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2160 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 383 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 414 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1161 ; 0.169 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 930 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 888 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 89 ; 0.173 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.105 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 18 ; 0.215 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.209 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1233 ; 2.340 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 485 ; 0.584 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1907 ; 3.374 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 785 ; 5.972 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 677 ; 7.628 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 230 REMARK 3 ORIGIN FOR THE GROUP (A): -0.5189 6.7533 22.7767 REMARK 3 T TENSOR REMARK 3 T11: -0.0506 T22: -0.0248 REMARK 3 T33: -0.0270 T12: 0.0053 REMARK 3 T13: -0.0056 T23: -0.0074 REMARK 3 L TENSOR REMARK 3 L11: 0.3414 L22: 1.2615 REMARK 3 L33: 0.6546 L12: -0.2833 REMARK 3 L13: 0.0476 L23: -0.5117 REMARK 3 S TENSOR REMARK 3 S11: -0.0098 S12: -0.0128 S13: 0.0151 REMARK 3 S21: -0.0017 S22: -0.0466 S23: -0.1042 REMARK 3 S31: 0.0049 S32: 0.0859 S33: 0.0564 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF REMARK 3 THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR REMARK 3 THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 3 4. RAMACHANDRAN OUTLIER OF RESIDUE ASP 180 IN SUBUNIT A IS REMARK 3 LOCATED IN POOR DENSITY. REMARK 3 5. RESIDUE GLU 183 IN SUBUNIT A IS DISORDERED AND NOT INCLUDED REMARK 3 IN THE MODEL. REMARK 3 6. ETHYLENE GLYCOL (EDO) MOLECULES FROM CRYO SOLUTION ARE MODELED. REMARK 4 REMARK 4 3B5P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045110. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000, 0.9797, 0.9796 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16846 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 28.736 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M MG(OAC)2, 20.0% PEG REMARK 280 8000, 0.1M CACODYLATE PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.25500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT SCATTERING REMARK 300 SUPPORTS THE ASSIGNMENT OF A MONOMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 183 REMARK 465 SER A 231 REMARK 465 GLU A 232 REMARK 465 VAL A 233 REMARK 465 VAL A 234 REMARK 465 LEU A 235 REMARK 465 SER A 236 REMARK 465 THR A 237 REMARK 465 ALA A 238 REMARK 465 ILE A 239 REMARK 465 ALA A 240 REMARK 465 GLN A 241 REMARK 465 HIS A 242 REMARK 465 HIS A 243 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 8 CE NZ REMARK 470 GLN A 133 OE1 NE2 REMARK 470 LEU A 152 CG CD1 CD2 REMARK 470 GLU A 164 CG CD OE1 OE2 REMARK 470 LEU A 179 CG CD1 CD2 REMARK 470 TRP A 182 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 182 CZ3 CH2 REMARK 470 GLU A 185 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 180 -100.29 -153.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 180 GLU A 181 147.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 246 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 377778 RELATED DB: TARGETDB REMARK 900 RELATED ID: 3B5O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CADD-LIKE PROTEIN OF UNKNOWN FUNCTION (ZP_ REMARK 900 00108531.1) FROM NOSTOC PUNCTIFORME PCC 73102 AT 1.35 A RESOLUTION REMARK 900 (HEXAGONAL FORM) REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. REMARK 999 2. THE SEQUENCE OF THIS PROTEIN WAS NOT AVAILABLE AT REMARK 999 THE UNIPROT KNOWLEDGEBASE DATABASE (UNIPROTKB) AT THE TIME REMARK 999 OF DEPOSITION. THE SEQUENCE INFORMATION IS AVAILABLE AT REMARK 999 GENBANK WITH ACCESSION CODE ZP_00108531.1 AND FROM THE REMARK 999 UNIPROT ARCHIVE (UNIPARC) UNDER ACCESSION ID UPI000038D4FF. DBREF 3B5P A 0 243 PDB 3B5P 3B5P 0 243 SEQRES 1 A 244 GLY MSE GLU PHE ASN HIS LEU THR LYS GLN LEU ASN GLN SEQRES 2 A 244 LEU LEU ALA GLN ASP TYR VAL ALA PHE SER ILE THR GLU SEQRES 3 A 244 ASN PRO VAL VAL GLN MSE LEU SER GLN ALA SER PHE ALA SEQRES 4 A 244 GLN ILE ALA TYR VAL MSE GLN GLN TYR SER ILE PHE PRO SEQRES 5 A 244 LYS GLU LEU VAL GLY PHE THR GLU LEU ALA ARG ARG LYS SEQRES 6 A 244 ALA LEU GLY ALA GLY TRP ASN GLY VAL ALA GLN GLU LEU SEQRES 7 A 244 GLN GLU ASN ILE ASP GLU GLU MSE GLY SER THR THR GLY SEQRES 8 A 244 GLY ILE SER HIS TYR THR LEU LEU ALA ASP GLY LEU GLU SEQRES 9 A 244 GLU GLY LEU GLY VAL ALA VAL LYS ASN THR MSE PRO SER SEQRES 10 A 244 VAL ALA THR SER LYS LEU LEU ARG THR VAL LEU SER LEU SEQRES 11 A 244 PHE ASP ARG GLN VAL ASP TYR VAL LEU GLY ALA THR TYR SEQRES 12 A 244 ALA ILE GLU ALA THR SER ILE PRO GLU LEU THR LEU ILE SEQRES 13 A 244 VAL LYS LEU VAL GLU TRP LEU HIS GLU GLY ALA ILE PRO SEQRES 14 A 244 LYS ASP LEU GLN TYR PHE PHE SER LYS HIS LEU ASP GLU SEQRES 15 A 244 TRP GLU ILE GLU HIS GLU ALA GLY LEU ARG THR SER VAL SEQRES 16 A 244 ALA ALA TYR ILE GLN PRO GLU GLU PHE GLY GLU PHE ALA SEQRES 17 A 244 ALA GLY PHE ARG ALA MSE ILE ASP ALA MSE GLN VAL TRP SEQRES 18 A 244 TRP GLN GLU LEU ALA GLN GLU ALA ILE SER SER GLU VAL SEQRES 19 A 244 VAL LEU SER THR ALA ILE ALA GLN HIS HIS MODRES 3B5P MSE A 1 MET SELENOMETHIONINE MODRES 3B5P MSE A 31 MET SELENOMETHIONINE MODRES 3B5P MSE A 44 MET SELENOMETHIONINE MODRES 3B5P MSE A 85 MET SELENOMETHIONINE MODRES 3B5P MSE A 114 MET SELENOMETHIONINE MODRES 3B5P MSE A 213 MET SELENOMETHIONINE MODRES 3B5P MSE A 217 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 31 8 HET MSE A 44 8 HET MSE A 85 16 HET MSE A 114 8 HET MSE A 213 8 HET MSE A 217 8 HET EDO A 244 4 HET EDO A 245 4 HET EDO A 246 4 HETNAM MSE SELENOMETHIONINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 7(C5 H11 N O2 SE) FORMUL 2 EDO 3(C2 H6 O2) FORMUL 5 HOH *143(H2 O) HELIX 1 1 GLY A 0 TYR A 18 1 19 HELIX 2 2 VAL A 19 SER A 22 5 4 HELIX 3 3 ASN A 26 MSE A 31 1 6 HELIX 4 4 LEU A 32 ALA A 35 5 4 HELIX 5 5 SER A 36 SER A 48 1 13 HELIX 6 6 SER A 48 ALA A 68 1 21 HELIX 7 7 TRP A 70 MSE A 85 1 16 HELIX 8 8 SER A 93 GLY A 107 1 15 HELIX 9 9 SER A 116 PHE A 130 1 15 HELIX 10 10 GLN A 133 HIS A 163 1 31 HELIX 11 11 PRO A 168 LEU A 179 1 12 HELIX 12 12 ILE A 184 ALA A 196 1 13 HELIX 13 13 GLN A 199 GLU A 201 5 3 HELIX 14 14 GLU A 202 ILE A 229 1 28 LINK C GLY A 0 N MSE A 1 1555 1555 1.32 LINK C MSE A 1 N GLU A 2 1555 1555 1.33 LINK C GLN A 30 N MSE A 31 1555 1555 1.33 LINK C MSE A 31 N LEU A 32 1555 1555 1.33 LINK C VAL A 43 N MSE A 44 1555 1555 1.34 LINK C MSE A 44 N GLN A 45 1555 1555 1.32 LINK C GLU A 84 N AMSE A 85 1555 1555 1.33 LINK C GLU A 84 N BMSE A 85 1555 1555 1.33 LINK C AMSE A 85 N GLY A 86 1555 1555 1.33 LINK C BMSE A 85 N GLY A 86 1555 1555 1.34 LINK C THR A 113 N MSE A 114 1555 1555 1.33 LINK C MSE A 114 N PRO A 115 1555 1555 1.32 LINK C ALA A 212 N MSE A 213 1555 1555 1.34 LINK C MSE A 213 N ILE A 214 1555 1555 1.34 LINK C ALA A 216 N MSE A 217 1555 1555 1.32 LINK C MSE A 217 N GLN A 218 1555 1555 1.34 SITE 1 AC1 4 ALA A 15 GLN A 16 GLU A 25 HOH A 389 SITE 1 AC2 3 PRO A 168 LYS A 169 ASP A 170 SITE 1 AC3 4 ALA A 38 TYR A 42 GLN A 45 HOH A 317 CRYST1 38.670 78.510 45.580 90.00 112.29 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025860 0.000000 0.010601 0.00000 SCALE2 0.000000 0.012737 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023711 0.00000